• No results found

University of Groningen Genetic susceptibility for inflammatory bowel disease across ethnicities and diseases van Sommeren, Suzanne

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Genetic susceptibility for inflammatory bowel disease across ethnicities and diseases van Sommeren, Suzanne"

Copied!
6
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Genetic susceptibility for inflammatory bowel disease across ethnicities and diseases

van Sommeren, Suzanne

DOI:

10.33612/diss.100597247

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

van Sommeren, S. (2019). Genetic susceptibility for inflammatory bowel disease across ethnicities and

diseases. Rijksuniversiteit Groningen. https://doi.org/10.33612/diss.100597247

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Printing of this thesis was financially supported by:

University of Groningen, University Medical Centre Groningen, Nederlandse Vereniging voor Gastroenerologie (NVGE), Norgine BV, Ferring BV, Teva Netherlands BV, Dr. Falk Pharma Benelux BV, Mylan BV, Pfizer BV and Lamepro BV.

ISBN (printed version): 978-94-034-2053-0 ISBN (electronic version): 978-94-034-2052-3

Cover design and layout: Lovebird design. www.lovebird-design.com Printing: Eikon +

Copyright © 2019 by Suzanne van Sommeren. All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, without prior permission of the author.

(3)

Genetic Susceptibility for

­Inflammatory­Bowel­Disease­across­

ethnicities­and­diseases

Proefschrift

ter verkrijging van de graad van doctor aan de

Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken

en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op

maandag 25 november 2019 om 12.45 uur

door

Suzanne van Sommeren

geboren op 17 december 1984

te Luyksgestel

(4)

Promotores

Prof. dr. R.K. Weersma

Prof. dr. C. Wijmenga

Beoordelingscommissie

Prof. dr .G. Bouma

Prof. dr. A. Zhernakova

Prof. dr. H.J. Verkade

Paranimfen

M.T.J. (Thecla) Wortelboer

A.M.L. (Marjolein) IJbema-Blom

(5)

TABLE OF CONTENTS

CHAPTER 1

Introduction and outline of the thesis ... 7

Part 1 Identification of genetic risk factors for Inflammatory Bowel Disease and the influence on gene expression ������������������������������������������������������������������� 19 CHAPTER 2 HNF4α and CDH1 are associated with ulcerative colitis in a Dutch cohort Inflammatory Bowel Diseases. 2011;17(8)1714–8 ... 21

CHAPTER 3 Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations Nature Genetics 2015;47(9):979–86 ... 31

CHAPTER 4 Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn’s diasease Human Molecular Genetics. 2010 Sep 1;19(17):3482–8 ... 53

CHAPTER 5 Correlation of genetic risk and mRNA expression in a Th17/IL23 pathway analysis in Inflammatory Bowel Disease Inflammatory Bowel Diseases. 2014;20(5):777–82... 67

Part 2 Genetic risk factors for Inflammatory Bowel Disease in other diseases �������������� 79 CHAPTER 6 Extra-intestinal manifestations and complications in inflammatory bowel disease – From shared genetics to shared biological pathways. Inflammatory Bowel Diseases 2014;20(6):987–94 ... 81

CHAPTER 7 Clinical and genetic characterization of patients with gastro-intestinal graft-vs.-host disease (GI-GVHD) after allogeneic hematopoietic cell transplantation suggests a role for JAK2, IL2RA and IL2. In preparation ... 95

CHAPTER 8 Conclusion, discussion and future perspectives ... 111

ADDENDUM Nederlandse samenvatting ... 125

List of publications ... 128

Curriculum Vitae ... 130

(6)

Referenties

GERELATEERDE DOCUMENTEN

Although genetic research in IBD has delivered many results, there are many more questions remaining in our research field regarding identification of genetic risk loci and

De projecten in dit proefschrift zijn mogelijk gemaakt met behulp van samples van het Nederlands Initiatief voor Crohn en Colitis (ICC) en samples verzameld binnen het

Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations Jimmy Z Liu*, Suzanne van Sommeren*,

Identifying an increasing number of genetic risk loci for inflam- matory bowel disease hardly increases the explained disease va- riance, but contributes to biological insights

Chapter 8 Identification of clinical and genetic parameters associated with hidradenitis suppurativa in inflammatory bowel disease. Inflamm Bowel Dis

In addition to these clinical parameters known to be associated with severe disease course, there are many factors whose effect on disease phenotype and disease course has not

Observers with less than 10 years of experience performed best at scoring disease severity (Table 4) and were significantly better at scoring UC severity than observers with

Participants: Since 2007, every patient with IBD treated in one of the eight Dutch university medical centres is asked to participate in the Dutch IBD Biobank in which 225